Tema Oncology ETF (CANC) Short Interest Ratio & Short Volume $24.54 -0.10 (-0.39%) As of 03/28/2025 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Short Interest DataTema Oncology ETF (CANC) has a short interest of 2,200 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a -69.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 11,430 shares to cover all short positions.Current Short Interest2,200 sharesPrevious Short Interest7,200 sharesChange Vs. Previous Month-69.44%Dollar Volume Sold Short$55,297.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares2,550,000 sharesShort Percent of Float0.08%Today's Trading Volume6,347 sharesAverage Trading Volume11,430 sharesToday's Volume Vs. Average56% Short Selling Tema Oncology ETF? Sign up to receive the latest short interest report for Tema Oncology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCANC Short Interest Over TimeCANC Days to Cover Over TimeCANC Percentage of Float Shorted Over Time Remove Ads Tema Oncology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20252,200 shares $55,297.00 -69.4%0.1%0.1 $25.14 2/28/20257,200 shares $184,608.00 +453.9%0.3%0.4 $25.64 2/15/20251,300 shares $32,682.00 -92.0%0.1%0.1 $25.14 1/31/202516,300 shares $418,747.00 +232.7%N/A0.9 $25.69 1/15/20254,900 shares $120,246.00 -33.8%N/A0.3 $24.54 12/31/20247,400 shares $179,894.00 +13.9%N/A0.6 $24.31 12/15/20246,500 shares $163,670.00 +195.5%N/A1.2 $25.18 11/30/20242,200 shares $61,208.40 +175.0%N/A0.8 $27.82 11/15/2024800 shares $20,952.00 -20.0%N/A0.3 $26.19 10/31/20241,000 shares $27,621.20 -37.5%N/A0.3 $27.62 10/15/20241,600 shares $45,712.00 -30.4%N/A0.4 $28.57 9/30/20242,300 shares $65,343.00 +283.3%N/A0.5 $28.41 9/15/2024600 shares $17,544.00 +50.0%N/A0.1 $29.24 8/31/2024400 shares $11,948.00 -87.9%N/A0 $29.87 8/15/20243,300 shares $94,677.00 -17.5%N/A0.2 $28.69 7/31/20244,000 shares $117,480.00 -80.7%N/A0.2 $29.37 7/15/202420,700 shares $607,752.00 No ChangeN/A1.2 $29.36 CANC Short Interest - Frequently Asked Questions What is Tema Oncology ETF's current short interest? Short interest is the volume of Tema Oncology ETF shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 2,200 shares of CANC short. 0.08% of Tema Oncology ETF's shares are currently sold short. Learn More on Tema Oncology ETF's current short interest. What is a good short interest percentage for Tema Oncology ETF? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Tema Oncology ETF's floating shares are currently sold short. Is Tema Oncology ETF's short interest increasing or decreasing? Tema Oncology ETF saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 2,200 shares, a decline of 69.4% from the previous total of 7,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tema Oncology ETF's short interest compare to its competitors? 0.08% of Tema Oncology ETF's shares are currently sold short. Here is how the short interest of companies compare to Tema Oncology ETF: Fidelity Disruptive Communications ETF (0.01%), Tradr 2X Long Innovation ETF (13.50%), Tema Cardiovascular and Metabolics ETF (0.02%), Invesco ESG NASDAQ 100 ETF (1.36%), Global X Aging Population ETF (0.04%), Global X E-Commerce ETF (0.10%), Global X Genomics & Biotechnology ETF (0.25%), Roundhill Daily 2X Long Magnificent Seven ETF (0.24%), Procure Space ETF (3.66%), Fidelity Disruptive Medicine ETF (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Tema Oncology ETF stock? Short selling CANC is an investing strategy that aims to generate trading profit from Tema Oncology ETF as its price is falling. CANC shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tema Oncology ETF? A short squeeze for Tema Oncology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CANC, which in turn drives the price of the stock up even further. How often is Tema Oncology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CANC, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies FDCF Short Interest Data TARK Short Interest Data HRTS Short Interest Data QQMG Short Interest Data AGNG Short Interest Data EBIZ Short Interest Data GNOM Short Interest Data MAGX Short Interest Data UFO Short Interest Data FMED Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CANC) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.